Publications

Below is a selection of publications arising from SEGCG-related collaborative research in esophageal and gastric cancer, reflecting Nordic multicenter cooperation and clinically relevant outcomes.

Selected Key Publications

  • Neoadjuvant chemotherapy versus chemoradiotherapy for oesophageal or gastro-oesophageal junction cancer
    Klevebro F, Alexandersson von Döbeln G, Wang N, et al. Annals of Oncology. 2016;27(4):660–667.
  • Long-term results of neoadjuvant chemotherapy versus chemoradiotherapy for oesophageal cancer
    Alexandersson von Döbeln G, Klevebro F, Jacobsen AB, et al. Diseases of the Esophagus. 2019;32(2).
  • Health-related quality of life after neoadjuvant chemotherapy versus chemoradiotherapy (NeoRes trial)
    Sunde B, Klevebro F, Johar A, et al. British Journal of Surgery. 2019;106(11):1452–1463.
  • Surgical morbidity and mortality after standard versus prolonged time to surgery (NeoRes II)
    Nilsson K, Klevebro F, Rouvelas I, et al. Annals of Surgery. 2020;272(5):684–689.
  • Oncological outcomes after standard versus prolonged time to surgery (NeoRes II)
    Nilsson K, Klevebro F, Sunde B, et al. Annals of Oncology. 2023;34(11):1015–1024.
  • Nasogastric tube after oesophagectomy and risk of anastomotic leak (KiNETIC trial)
    Hedberg J, Kauppila JH, Aahlin EK, et al. The Lancet Regional Health – Europe. 2025;57:101411.
  • NEEDS trial protocol: Surgery versus definitive chemoradiotherapy with salvage surgery
    Nilsson M, Olafsdottir H, Alexandersson von Döbeln G, et al. Frontiers in Oncology. 2022;12:917961.

Additional Publications

  • Morbidity and mortality after surgery following neoadjuvant chemotherapy versus chemoradiotherapy
    Klevebro F, Tsai JA, Jacobsen AB, et al. European Journal of Surgical Oncology. 2015;41(7):920–926.
  • Perioperative hemodynamics after neoadjuvant chemo- or chemoradiotherapy
    Lund M, Tsai JA, Nilsson M, et al. European Journal of Anaesthesiology. 2016;33(9):653–661.
  • Effect of neoadjuvant chemoradiotherapy versus chemotherapy on dysphagia relief
    Sunde B, Johnsen G, Jacobsen AB, et al. Diseases of the Esophagus. 2019;32(2).
  • Nutritional outcomes after standard versus prolonged time to surgery
    Ericson J, Klevebro F, Sunde B, et al. European Journal of Surgical Oncology. 2025;51(9).
  • Feasibility and safety of laparoscopic D2 gastrectomy combined with PIPAC (PIPAC-OPC4)
    Graversen M, Rouvelas I, Ainsworth AP, et al. Annals of Surgical Oncology. 2023;30(7):4433–4441.
  • Curative treatment for oligometastatic gastroesophageal cancer
    Noren N, Rouvelas I, Lundell L, et al. Langenbeck’s Archives of Surgery. 2024;410(1):10.
  • KiNETIC trial protocol: Nasogastric tube use after oesophagectomy
    Hedberg J, Sundbom M, Edholm D, et al. Diseases of the Esophagus. 2024;37(6):doae010.